{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:48:10Z","timestamp":1793159290888,"version":"4.5.0"},"reference-count":166,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1038\/s41581-021-00488-2","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T04:19:49Z","timestamp":1633580389000},"page":"38-55","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":164,"title":["Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7662-2362","authenticated-orcid":false,"given":"Judy","family":"Baek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0500-1526","authenticated-orcid":false,"given":"Chenchen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3051-3141","authenticated-orcid":false,"given":"Farsad","family":"Afshinnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Michailidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramaniam","family":"Pennathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,6]]},"reference":[{"key":"488_CR1","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2021.01.002","volume":"77","author":"KL Johansen","year":"2021","unstructured":"Johansen, K. L. et al. US Renal Data System 2020 annual data report: epidemiology of kidney disease in the United States. Am. J. Kidney Dis. 77, A7\u2013A8 (2021).","journal-title":"Am. J. Kidney Dis."},{"key":"488_CR2","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","volume":"108","author":"MJ Sarnak","year":"2003","unstructured":"Sarnak, M. J. et al. Kidney disease as a risk factor for development of cardiovascular disease. Circulation 108, 2154\u20132169 (2003).","journal-title":"Circulation"},{"key":"488_CR3","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41581-021-00423-5","volume":"17","author":"H Noels","year":"2021","unstructured":"Noels, H., Lehrke, M., Vanholder, R. & Jankowski, J. Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations. Nat. Rev. Nephrol. 17, 528\u2013542 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"488_CR4","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1681\/ASN.2014070714","volume":"26","author":"S Thompson","year":"2015","unstructured":"Thompson, S. et al. Cause of death in patients with reduced kidney function. J. Am. Soc. Nephrol. 26, 2504\u20132511 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"488_CR5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cbi.2014.06.029","volume":"220","author":"YY Zhao","year":"2014","unstructured":"Zhao, Y. Y., Wu, S. P., Liu, S., Zhang, Y. & Lin, R. C. Ultra-performance liquid chromatography\u2013mass spectrometry as a sensitive and powerful technology in lipidomic applications. Chem. Biol. Interact. 220, 181\u2013192 (2014).","journal-title":"Chem. Biol. Interact."},{"key":"488_CR6","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1021\/acs.analchem.7b04424","volume":"90","author":"C Guijas","year":"2018","unstructured":"Guijas, C. et al. METLIN: a technology platform for identifying knowns and unknowns. Anal. Chem. 90, 3156\u20133164 (2018).","journal-title":"Anal. Chem."},{"key":"488_CR7","doi-asserted-by":"crossref","first-page":"D507","DOI":"10.1093\/nar\/gkj122","volume":"34","author":"D Cotter","year":"2006","unstructured":"Cotter, D., Maer, A., Guda, C., Saunders, B. & Subramaniam, S. LMPD: LIPID MAPS proteome database. Nucleic Acids Res. 34, D507\u2013D510 (2006).","journal-title":"Nucleic Acids Res."},{"key":"488_CR8","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3390\/ijms12010588","volume":"12","author":"GS Richmond","year":"2011","unstructured":"Richmond, G. S. & Smith, T. K. Phospholipases A1. Int. J. Mol. Sci. 12, 588\u2013612 (2011).","journal-title":"Int. J. Mol. Sci."},{"key":"488_CR9","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1021\/acs.analchem.5b04491","volume":"88","author":"T Cajka","year":"2016","unstructured":"Cajka, T. & Fiehn, O. Toward merging untargeted and targeted methods in mass spectrometry-based metabolomics and lipidomics. Anal. Chem. 88, 524\u2013545 (2016).","journal-title":"Anal. Chem."},{"key":"488_CR10","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s00216-019-02241-y","volume":"412","author":"T Z\u00fcllig","year":"2020","unstructured":"Z\u00fcllig, T., Tr\u00f6tzm\u00fcller, M. & K\u00f6feler, H. C. Lipidomics from sample preparation to data analysis: a primer. Anal. Bioanal. Chem. 412, 2191\u20132209 (2020).","journal-title":"Anal. Bioanal. Chem."},{"key":"488_CR11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.semnephrol.2018.01.004","volume":"38","author":"F Afshinnia","year":"2018","unstructured":"Afshinnia, F. et al. Lipidomics and biomarker discovery in kidney disease. Semin. Nephrol. 38, 127\u2013141 (2018).","journal-title":"Semin. Nephrol."},{"key":"488_CR12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2215\/CJN.07070618","volume":"14","author":"EP Rhee","year":"2019","unstructured":"Rhee, E. P. et al. Variability of two metabolomic platforms in CKD. Clin. J. Am. Soc. Nephrol. 14, 40\u201348 (2019).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"488_CR13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"488_CR14","doi-asserted-by":"crossref","first-page":"D608","DOI":"10.1093\/nar\/gkx1089","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart, D. S. et al. HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res. 46, D608\u2013D617 (2018).","journal-title":"Nucleic Acids Res."},{"key":"488_CR15","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130317","volume":"4","author":"F Afshinnia","year":"2019","unstructured":"Afshinnia, F. et al. Increased lipogenesis and impaired \u03b2-oxidation predict type 2 diabetic kidney disease progression in American Indians. JCI Insight 4, e130317 (2019).","journal-title":"JCI Insight"},{"key":"488_CR16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1681\/ASN.2017030350","volume":"29","author":"F Afshinnia","year":"2018","unstructured":"Afshinnia, F. et al. Impaired \u03b2-oxidation and altered complex lipid fatty acid partitioning with advancing CKD. J. Am. Soc. Nephrol. 29, 295\u2013306 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"488_CR17","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/bioinformatics\/btx012","volume":"33","author":"S Basu","year":"2017","unstructured":"Basu, S. et al. Sparse network modeling and metscape-based visualization methods for the analysis of large-scale metabolomics data. Bioinformatics 33, 1545\u20131553 (2017).","journal-title":"Bioinformatics"},{"key":"488_CR18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.copbio.2016.04.009","volume":"39","author":"J Krumsiek","year":"2016","unstructured":"Krumsiek, J., Bartel, J. & Theis, F. J. Computational approaches for systems metabolomics. Curr. Opin. Biotechnol. 39, 198\u2013206 (2016).","journal-title":"Curr. Opin. Biotechnol."},{"key":"488_CR19","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1093\/bioinformatics\/btz114","volume":"35","author":"J Ma","year":"2019","unstructured":"Ma, J. et al. Differential network enrichment analysis reveals novel lipid pathways in chronic kidney disease. Bioinformatics 35, 3441\u20133452 (2019).","journal-title":"Bioinformatics"},{"key":"488_CR20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ekir.2016.08.007","volume":"1","author":"F Afshinnia","year":"2016","unstructured":"Afshinnia, F. et al. Lipidomic signature of progression of chronic kidney disease in the chronic renal insufficiency cohort. Kidney Int. Rep. 1, 256\u2013268 (2016).","journal-title":"Kidney Int. Rep."},{"key":"488_CR21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/bioinformatics\/btr661","volume":"28","author":"A Karnovsky","year":"2012","unstructured":"Karnovsky, A. et al. Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data. Bioinformatics 28, 373\u2013380 (2012).","journal-title":"Bioinformatics"},{"key":"488_CR22","doi-asserted-by":"publisher","DOI":"10.1177\/1177932219899051","author":"I Subramanian","year":"2020","unstructured":"Subramanian, I., Verma, S., Kumar, S., Jere, A. & Anamika, K. Multi-omics data integration, interpretation, and its application. Bioinforma. Biol. Insights https:\/\/doi.org\/10.1177\/1177932219899051 (2020).","journal-title":"Bioinforma. Biol. Insights"},{"key":"488_CR23","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.celrep.2019.04.012","volume":"27","author":"PT Brinkkoetter","year":"2019","unstructured":"Brinkkoetter, P. T. et al. Anaerobic glycolysis maintains the glomerular filtration barrier independent of mitochondrial metabolism and dynamics. Cell Rep. 27, 1551\u20131566.e5 (2019).","journal-title":"Cell Rep."},{"key":"488_CR24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrneph.2018.9","volume":"14","author":"JM Forbes","year":"2018","unstructured":"Forbes, J. M. & Thorburn, D. R. Mitochondrial dysfunction in diabetic kidney disease. Nat. Rev. Nephrol. 14, 291\u2013312 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"488_CR25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev.ph.47.030185.000505","volume":"47","author":"LJ Mandel","year":"1985","unstructured":"Mandel, L. J. Metabolic substrates, cellular energy production, and the regulation of proximal tubular transport. Annu. Rev. Physiol. 47, 85\u2013101 (1985).","journal-title":"Annu. Rev. Physiol."},{"key":"488_CR26","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1194\/jlr.M074427","volume":"58","author":"D Scerbo","year":"2017","unstructured":"Scerbo, D. et al. Kidney triglyceride accumulation in the fasted mouse is dependent upon serum free fatty acids. J. Lipid Res. 58, 1132\u20131142 (2017).","journal-title":"J. Lipid Res."},{"key":"488_CR27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1681\/ASN.2017030314","volume":"29","author":"S Khan","year":"2018","unstructured":"Khan, S. et al. Kidney proximal tubule lipoapoptosis is regulated by fatty acid transporter-2 (FATP2). J. Am. Soc. Nephrol. 29, 81\u201391 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"488_CR28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","volume":"21","author":"HM Kang","year":"2015","unstructured":"Kang, H. M. et al. Defective fatty acid oxidation in renal tubular epithelial cells plays a key role in kidney fibrosis development. Nat. Med. 21, 37\u201346 (2015).","journal-title":"Nat. Med."},{"key":"488_CR29","doi-asserted-by":"crossref","first-page":"F401","DOI":"10.1152\/ajprenal.00454.2013","volume":"306","author":"K Kampe","year":"2014","unstructured":"Kampe, K., Sieber, J., Orellana, J. M., Mundel, P. & Jehle, A. W. Susceptibility of podocytes to palmitic acid is regulated by fatty acid oxidation and inversely depends on acetyl-CoA carboxylases 1 and 2. Am. J. Physiol. Ren. Physiol. 306, F401\u2013F409 (2014).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"488_CR30","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/ki.2012.188","volume":"82","author":"Y Yuan","year":"2012","unstructured":"Yuan, Y. et al. Activation of peroxisome proliferator-activated receptor-\u03b3 coactivator 1\u03b1 ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury. Kidney Int. 82, 771\u2013789 (2012).","journal-title":"Kidney Int."},{"key":"488_CR31","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1172\/JCI58662","volume":"121","author":"M Tran","year":"2011","unstructured":"Tran, M. et al. PGC-1\u03b1 promotes recovery after acute kidney injury during systemic inflammation in mice. J. Clin. Invest. 121, 4003\u20134014 (2011).","journal-title":"J. Clin. Invest."},{"key":"488_CR32","doi-asserted-by":"crossref","first-page":"F1071","DOI":"10.1152\/ajprenal.90208.2008","volume":"295","author":"H Zhang","year":"2008","unstructured":"Zhang, H. et al. Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. Am. J. Physiol. Ren. Physiol. 295, F1071\u2013F1081 (2008).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"488_CR33","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140695","volume":"131","author":"V Miguel","year":"2021","unstructured":"Miguel, V. et al. Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis. J. Clin. Invest. 131, e140695 (2021).","journal-title":"J. Clin. Invest."},{"key":"488_CR34","doi-asserted-by":"crossref","first-page":"F1006","DOI":"10.1152\/ajprenal.00021.2012","volume":"303","author":"RJ Baines","year":"2012","unstructured":"Baines, R. J. et al. CD36 mediates proximal tubular binding and uptake of albumin and is upregulated in proteinuric nephropathies. Am. J. Physiol. Ren. Physiol. 303, F1006\u2013F1014 (2012).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"488_CR35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1194\/jlr.P040501","volume":"55","author":"M Herman-Edelstein","year":"2014","unstructured":"Herman-Edelstein, M., Scherzer, P., Tobar, A., Levi, M. & Gafter, U. Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy. J. Lipid Res. 55, 561\u2013572 (2014).","journal-title":"J. Lipid Res."},{"key":"488_CR36","volume":"10","author":"W Hua","year":"2015","unstructured":"Hua, W. et al. CD36 mediated fatty acid-induced podocyte apoptosis via oxidative stress. PLoS One 10, e0127507 (2015).","journal-title":"PLoS One"},{"key":"488_CR37","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1681\/ASN.2008010009","volume":"20","author":"DM Okamura","year":"2009","unstructured":"Okamura, D. M. et al. CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKD. J. Am. Soc. Nephrol. 20, 495\u2013505 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"488_CR38","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.kint.2015.12.043","volume":"89","author":"ACP Souza","year":"2016","unstructured":"Souza, A. C. P. et al. Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation. Kidney Int. 89, 809\u2013822 (2016).","journal-title":"Kidney Int."},{"key":"488_CR39","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1194\/jlr.M076216","volume":"58","author":"P Yang","year":"2017","unstructured":"Yang, P. et al. Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice. J. Lipid Res. 58, 1417\u20131427 (2017).","journal-title":"J. Lipid Res."},{"key":"488_CR40","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/jcb.21236","volume":"101","author":"YL Yang","year":"2007","unstructured":"Yang, Y. L. et al. CD36 is a novel and potential anti-fibrogenic target in albumin-induced renal proximal tubule fibrosis. J. Cell. Biochem. 101, 735\u2013744 (2007).","journal-title":"J. Cell. Biochem."},{"key":"488_CR41","doi-asserted-by":"crossref","first-page":"F1720","DOI":"10.1152\/ajprenal.00536.2017","volume":"315","author":"LC Li","year":"2018","unstructured":"Li, L. C. et al. Palmitate aggravates proteinuria-induced cell death and inflammation via CD36-inflammasome axis in the proximal tubular cells of obese mice. Am. J. Physiol. Ren. Physiol. 315, F1720\u2013F1731 (2018).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"488_CR42","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.bbadis.2015.03.010","volume":"1852","author":"W Cui","year":"2015","unstructured":"Cui, W. et al. Interaction of thrombospondin1 and CD36 contributes to obesity-associated podocytopathy. Biochim. Biophys. Acta 1852, 1323\u20131333 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"488_CR43","doi-asserted-by":"crossref","first-page":"103162","DOI":"10.1016\/j.ebiom.2020.103162","volume":"63","author":"J-J Kim","year":"2021","unstructured":"Kim, J.-J. et al. Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndrome. EBioMedicine 63, 103162 (2021).","journal-title":"EBioMedicine"},{"key":"488_CR44","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/HYPERTENSIONAHA.112.198770","volume":"61","author":"DJ Kennedy","year":"2013","unstructured":"Kennedy, D. J. et al. CD36 and Na\/K-ATPase-\u03b11 form a pro-inflammatory signaling loop in kidney. Hypertension 61, 216\u2013224 (2013).","journal-title":"Hypertension"},{"key":"488_CR45","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.ajpath.2015.04.016","volume":"185","author":"S Pennathur","year":"2015","unstructured":"Pennathur, S. et al. The macrophage phagocytic receptor CD36 promotes fibrogenic pathways on removal of apoptotic cells during chronic kidney injury. Am. J. Pathol. 185, 2232\u20132245 (2015).","journal-title":"Am. J. Pathol."},{"key":"488_CR46","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrneph.2017.126","volume":"13","author":"X Yang","year":"2017","unstructured":"Yang, X. et al. CD36 in chronic kidney disease: novel insights and therapeutic opportunities. Nat. Rev. Nephrol. 13, 769\u2013781 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"488_CR47","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1681\/ASN.2015020190","volume":"27","author":"S Kuwahara","year":"2016","unstructured":"Kuwahara, S. et al. Megalin-mediated tubuloglomerular alterations in high-fat diet-induced kidney disease. J. Am. Soc. Nephrol. 27, 1996\u20132008 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"488_CR48","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136845","volume":"5","author":"S Khan","year":"2020","unstructured":"Khan, S. et al. Fatty acid transport protein-2 regulates glycemic control and diabetic kidney disease progression. JCI Insight 5, e136845 (2020).","journal-title":"JCI Insight"},{"key":"488_CR49","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1523-1755.2005.00061.x","volume":"67","author":"RA Zager","year":"2005","unstructured":"Zager, R. A., Johnson, A. C. M. & Hanson, S. Y. Renal tubular triglyercide accumulation following endotoxic, toxic, and ischemic injury. Kidney Int. 67, 111\u2013121 (2005).","journal-title":"Kidney Int."},{"key":"488_CR50","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1111\/j.1523-1755.2005.00325.x","volume":"67","author":"ALICM Johnson","year":"2005","unstructured":"Johnson, A. L. I. C. M., Stahl, A. & Zager, R. A. Triglyceride accumulation in injured renal tubular cells: alterations in both synthetic and catabolic pathways. Kidney Int. 67, 2196\u20132209 (2005).","journal-title":"Kidney Int."},{"key":"488_CR51","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/sj.ki.5001834","volume":"70","author":"JM Weinberg","year":"2006","unstructured":"Weinberg, J. M. Lipotoxicity. Kidney Int. 70, 1560\u20131566 (2006).","journal-title":"Kidney Int."},{"key":"488_CR52","doi-asserted-by":"crossref","first-page":"32317","DOI":"10.1074\/jbc.M500801200","volume":"280","author":"T Jiang","year":"2005","unstructured":"Jiang, T. et al. Diet-induced obesity in C57BL\/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J. Biol. Chem. 280, 32317\u201332325 (2005).","journal-title":"J. Biol. Chem."},{"key":"488_CR53","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.3390\/ijms21124359","volume":"21","author":"YC Lin","year":"2020","unstructured":"Lin, Y. C. et al. Nifedipine exacerbates lipogenesis in the kidney via KIM-1, CD36, and SREBP upregulation: implications from an animal model for human study. Int. J. Mol. Sci. 21, 4359 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"488_CR54","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1021\/acs.jproteome.6b00956","volume":"16","author":"H Chen","year":"2017","unstructured":"Chen, H. et al. Combined clinical phenotype and lipidomic analysis reveals the impact of chronic kidney disease on lipid metabolism. J. Proteome Res. 16, 1566\u20131578 (2017).","journal-title":"J. Proteome Res."},{"key":"488_CR55","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3390\/ijms20071719","volume":"20","author":"M Szczuko","year":"2019","unstructured":"Szczuko, M. et al. Comparison of fatty acid profiles in a group of female patients with chronic kidney diseases (CKD) and metabolic syndrome (MetS)\u2013similar trends of changes, different pathophysiology. Int. J. Mol. Sci. 20, 1719 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"488_CR56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12944-020-01258-y","volume":"19","author":"M Szczuko","year":"2020","unstructured":"Szczuko, M. et al. The C18:3n6\/C22:4n6 ratio is a good lipid marker of chronic kidney disease (CKD) progression. Lipids Health Dis. 19, 77 (2020).","journal-title":"Lipids Health Dis."},{"key":"488_CR57","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.2337\/dc21-0737","volume":"44","author":"F Afshinnia","year":"2021","unstructured":"Afshinnia, F. et al. Circulating free fatty acid and phospholipid signature predicts early rapid kidney function decline in patients with type 1 diabetes. Diabetes Care 44, 2098\u20132106 (2021).","journal-title":"Diabetes Care"},{"key":"488_CR58","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1073\/pnas.0630588100","volume":"100","author":"LL Listenberger","year":"2003","unstructured":"Listenberger, L. L. et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc. Natl Acad. Sci. USA 100, 3077\u20133082 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"488_CR59","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1016\/j.celrep.2018.08.015","volume":"24","author":"D Ackerman","year":"2018","unstructured":"Ackerman, D. et al. Triglycerides promote lipid homeostasis during hypoxic stress by balancing fatty acid saturation. Cell Rep. 24, 2596\u20132605.e5 (2018).","journal-title":"Cell Rep."},{"key":"488_CR60","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.3390\/ijms20102470","volume":"20","author":"A Czumaj","year":"2019","unstructured":"Czumaj, A. et al. Alterations of fatty acid profile may contribute to dyslipidemia in chronic kidney disease by influencing hepatocyte metabolism. Int. J. Mol. Sci. 20, 2470 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"488_CR61","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1021\/acs.jproteome.6b00170","volume":"15","author":"L Wang","year":"2016","unstructured":"Wang, L. et al. Plasma lipidomics investigation of hemodialysis effects by using liquid chromatography-mass spectrometry. J. Proteome Res. 15, 1986 (2016).","journal-title":"J. Proteome Res."},{"key":"488_CR62","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ajpath.2013.05.023","volume":"183","author":"J Sieber","year":"2013","unstructured":"Sieber, J. et al. Susceptibility of podocytes to palmitic acid is regulated by stearoyl-CoA desaturases 1 and 2. Am. J. Pathol. 183, 735\u2013744 (2013).","journal-title":"Am. J. Pathol."},{"key":"488_CR63","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.3390\/ijms17111868","volume":"17","author":"T Iwai","year":"2016","unstructured":"Iwai, T. et al. Stearoyl-CoA desaturase-1 protects cells against lipotoxicity-mediated apoptosis in proximal tubular cells. Int. J. Mol. Sci. 17, 1868 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"488_CR64","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/BF03346760","volume":"36","author":"DA de Luis","year":"2013","unstructured":"de Luis, D. A., Izaola, O., Aller, R., de La Fuente, B. & Pacheco, D. Effects of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) on weight loss, adipocytokines levels, and insulin resistance after a high polyunsaturated fat diet in obese patients. J. Endocrinol. Invest. 36, 965\u2013969 (2013).","journal-title":"J. Endocrinol. Invest."},{"key":"488_CR65","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.nut.2017.03.008","volume":"41","author":"JL Stevenson","year":"2017","unstructured":"Stevenson, J. L., Paton, C. M. & Cooper, J. A. Hunger and satiety responses to high-fat meals after a high-polyunsaturated fat diet: a randomized trial. Nutrition 41, 14\u201323 (2017).","journal-title":"Nutrition"},{"key":"488_CR66","doi-asserted-by":"crossref","first-page":"38870","DOI":"10.1074\/jbc.M106219200","volume":"276","author":"S Cases","year":"2001","unstructured":"Cases, S. et al. Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. J. Biol. Chem. 276, 38870\u201338876 (2001).","journal-title":"J. Biol. Chem."},{"key":"488_CR67","doi-asserted-by":"crossref","first-page":"18667","DOI":"10.1074\/jbc.M412062200","volume":"280","author":"HA Hostetler","year":"2005","unstructured":"Hostetler, H. A., Petrescu, A. D., Kier, A. B. & Schroeder, F. Peroxisome proliferator-activated receptor \u03b1 interacts with high affinity and is conformationally responsive to endogenous ligands. J. Biol. Chem. 280, 18667\u201318682 (2005).","journal-title":"J. Biol. Chem."},{"key":"488_CR68","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1073\/pnas.94.9.4318","volume":"94","author":"SA Kliewer","year":"1997","unstructured":"Kliewer, S. A. et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors \u03b1 and \u03b3. Proc. Natl Acad. Sci. USA 94, 4318\u20134323 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"488_CR69","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bbrc.2010.10.012","volume":"402","author":"M Soumura","year":"2010","unstructured":"Soumura, M. et al. Oleate and eicosapentaenoic acid attenuate palmitate-induced inflammation and apoptosis in renal proximal tubular cell. Biochem. Biophys. Res. Commun. 402, 265\u2013271 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"488_CR70","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000038493.65177.94","volume":"106","author":"PM Kris-Etherton","year":"2002","unstructured":"Kris-Etherton, P. M., Harris, W. S. & Appel, L. J. Nutrition Committee Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106, 2747\u20132757 (2002).","journal-title":"Circulation"},{"key":"488_CR71","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.cmet.2018.12.023","volume":"29","author":"W Kim","year":"2019","unstructured":"Kim, W. et al. Polyunsaturated fatty acid desaturation is a mechanism for glycolytic NAD+ recycling. Cell Metab. 29, 856\u2013870.e7 (2019).","journal-title":"Cell Metab."},{"key":"488_CR72","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.3390\/nu7115480","volume":"7","author":"R Crescenzo","year":"2015","unstructured":"Crescenzo, R. et al. Fat quality influences the obesogenic effect of high fat diets. Nutrients 7, 9475\u20139491 (2015).","journal-title":"Nutrients"},{"key":"488_CR73","doi-asserted-by":"crossref","first-page":"E777","DOI":"10.1152\/ajpendo.00617.2014","volume":"309","author":"A Ruiz-Ram\u00edrez","year":"2015","unstructured":"Ruiz-Ram\u00edrez, A., Barrios-Maya, M.-A., L\u00f3pez-Acosta, O., Molina-Ortiz, D. & El-Hafidi, M. Cytochrome c release from rat liver mitochondria is compromised by increased saturated cardiolipin species induced by sucrose feeding. Am. J. Physiol. Endocrinol. Metab. 309, E777\u2013E786 (2015).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"488_CR74","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1016\/j.celrep.2020.02.115","volume":"30","author":"G Oemer","year":"2020","unstructured":"Oemer, G. et al. Phospholipid acyl chain diversity controls the tissue-specific assembly of mitochondrial cardiolipins. Cell Rep. 30, 4281\u20134291.e4 (2020).","journal-title":"Cell Rep."},{"key":"488_CR75","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1681\/ASN.2017030247","volume":"28","author":"HH Szeto","year":"2017","unstructured":"Szeto, H. H. Pharmacologic approaches to improve mitochondrial function in AKI and CKD. J. Am. Soc. Nephrol. 28, 2856\u20132865 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"488_CR76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149033","volume":"11","author":"G Cavaliere","year":"2016","unstructured":"Cavaliere, G. et al. Polyunsaturated fatty acids attenuate diet induced obesity and insulin resistance, modulating mitochondrial respiratory uncoupling in rat skeletal muscle. PLoS One 11, e0149033 (2016).","journal-title":"PLoS One"},{"key":"488_CR77","doi-asserted-by":"crossref","first-page":"15447","DOI":"10.3390\/ijms131115447","volume":"13","author":"CH Cortie","year":"2012","unstructured":"Cortie, C. H. & Else, P. L. Dietary docosahexaenoic acid (22:6) incorporates into cardiolipin at the expense of linoleic acid (18:2): analysis and potential implications. Int. J. Mol. Sci. 13, 15447\u201315463 (2012).","journal-title":"Int. J. Mol. Sci."},{"key":"488_CR78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034402","volume":"7","author":"RJ Khairallah","year":"2012","unstructured":"Khairallah, R. J. et al. Improved mitochondrial function with diet-induced increase in either docosahexaenoic acid or arachidonic acid in membrane phospholipids. PLoS One 7, e34402 (2012).","journal-title":"PLoS One"},{"key":"488_CR79","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1113\/jphysiol.2013.267336","volume":"592","author":"EaF Herbst","year":"2014","unstructured":"Herbst, Ea. F. et al. Omega-3 supplementation alters mitochondrial membrane composition and respiration kinetics in human skeletal muscle. J. Physiol. 592, 1341\u20131352 (2014).","journal-title":"J. Physiol."},{"key":"488_CR80","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/cvr\/cvs118","volume":"94","author":"CM Mulligan","year":"2012","unstructured":"Mulligan, C. M. et al. Dietary linoleate preserves cardiolipin and attenuates mitochondrial dysfunction in the failing rat heart. Cardiovasc. Res. 94, 460\u2013468 (2012).","journal-title":"Cardiovasc. Res."},{"key":"488_CR81","first-page":"CD012345","volume":"7","author":"AS Abdelhamid","year":"2018","unstructured":"Abdelhamid, A. S. et al. Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 7, CD012345 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"488_CR82","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.numecd.2017.10.010","volume":"27","author":"PM Clifton","year":"2017","unstructured":"Clifton, P. M. & Keogh, J. B. A systematic review of the effect of dietary saturated and polyunsaturated fat on heart disease. Nutr. Metab. Cardiovasc. Dis. 27, 1060\u20131080 (2017).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"488_CR83","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3945\/jn.108.098251","volume":"139","author":"M-P St-Onge","year":"2009","unstructured":"St-Onge, M.-P., Zhang, S., Darnell, B. & Allison, D. B. Baseline serum C-reactive protein is associated with lipid responses to low-fat and high-polyunsaturated fat diets. J. Nutr. 139, 680\u2013683 (2009).","journal-title":"J. Nutr."},{"key":"488_CR84","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00592-018-1213-0","volume":"55","author":"I Ibarra-Gonz\u00e1lez","year":"2018","unstructured":"Ibarra-Gonz\u00e1lez, I. et al. Optimization of kidney dysfunction prediction in diabetic kidney disease using targeted metabolomics. Acta Diabetol. 55, 1151\u20131161 (2018).","journal-title":"Acta Diabetol."},{"key":"488_CR85","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ekir.2016.12.003","volume":"2","author":"J-J Liu","year":"2016","unstructured":"Liu, J.-J. et al. Profiling of plasma metabolites suggests altered mitochondrial fuel usage and remodeling of sphingolipid metabolism in individuals with type 2 diabetes and kidney disease. Kidney Int. Rep. 2, 470\u2013480 (2016).","journal-title":"Kidney Int. Rep."},{"key":"488_CR86","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jchromb.2019.04.003","volume":"1117","author":"M Kordalewska","year":"2019","unstructured":"Kordalewska, M. et al. Multiplatform metabolomics provides insight into the molecular basis of chronic kidney disease. J. Chromatogr. B 1117, 49\u201357 (2019).","journal-title":"J. Chromatogr. B"},{"key":"488_CR87","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1258\/0004563054889954","volume":"42","author":"SE Reuter","year":"2005","unstructured":"Reuter, S. E. et al. Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease. Ann. Clin. Biochem. 42, 387\u2013393 (2005).","journal-title":"Ann. Clin. Biochem."},{"key":"488_CR88","volume":"2","author":"S Kalim","year":"2013","unstructured":"Kalim, S. et al. A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients. J. Am. Heart Assoc. Cardiovasc. Cerebrovasc. Dis. 2, e000542 (2013).","journal-title":"J. Am. Heart Assoc. Cardiovasc. Cerebrovasc. Dis."},{"key":"488_CR89","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/ki.2015.199","volume":"88","author":"HC Looker","year":"2015","unstructured":"Looker, H. C. et al. Biomarkers of rapid chronic kidney disease progression in type 2 diabetes. Kidney Int. 88, 888\u2013896 (2015).","journal-title":"Kidney Int."},{"key":"488_CR90","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/ki.2013.497","volume":"85","author":"MA Niewczas","year":"2014","unstructured":"Niewczas, M. A. et al. Uremic solutes and risk of end stage renal disease in type 2 diabetes. Kidney Int. 85, 1214\u20131224 (2014).","journal-title":"Kidney Int."},{"key":"488_CR91","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11306-011-0291-6","volume":"8","author":"FM van der Kloet","year":"2012","unstructured":"van der Kloet, F. M. et al. Discovery of early-stage biomarkers for diabetic kidney disease using MS-based metabolomics (FinnDiane study). Metabolomics 8, 109\u2013119 (2012).","journal-title":"Metabolomics"},{"key":"488_CR92","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/j.ajkd.2012.01.014","volume":"60","author":"O-N Goek","year":"2012","unstructured":"Goek, O.-N. et al. Serum metabolite concentrations and decreased GFR in the general population. Am. J. Kidney Dis. 60, 197\u2013206 (2012).","journal-title":"Am. J. Kidney Dis."},{"key":"488_CR93","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2215\/CJN.07650717","volume":"13","author":"F Wang","year":"2018","unstructured":"Wang, F. et al. Associations of plasma amino acid and acylcarnitine profiles with incident reduced glomerular filtration rate. Clin. J. Am. Soc. Nephrol. 13, 560\u2013568 (2018).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"488_CR94","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cmet.2007.10.013","volume":"7","author":"TR Koves","year":"2008","unstructured":"Koves, T. R. et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7, 45\u201356 (2008).","journal-title":"Cell Metab."},{"key":"488_CR95","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0149-2918(95)80017-4","volume":"17","author":"EP Brass","year":"1995","unstructured":"Brass, E. P. Pharmacokinetic considerations for the therapeutic use of carnitine in hemodialysis patients. Clin. Ther. 17, 176\u2013185 (1995).","journal-title":"Clin. Ther."},{"key":"488_CR96","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1210\/jc.2016-1859","volume":"101","author":"G Xu","year":"2016","unstructured":"Xu, G. et al. Liver and muscle contribute differently to the plasma acylcarnitine pool during fasting and exercise in humans. J. Clin. Endocrinol. Metab. 101, 5044\u20135052 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"488_CR97","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1053\/j.jrn.2006.01.004","volume":"16","author":"D Fouque","year":"2006","unstructured":"Fouque, D. et al. Relationship between serum carnitine, acylcarnitines, and renal function in patients with chronic renal disease. J. Ren. Nutr. 16, 125\u2013131 (2006).","journal-title":"J. Ren. Nutr."},{"key":"488_CR98","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/ndt\/gfr334","volume":"27","author":"WJA Murphy","year":"2012","unstructured":"Murphy, W. J. A. et al. Altered carnitine metabolism in dialysis patients with reduced physical function may be due to dysfunctional fatty acid oxidation. Nephrol. Dial. Transplant. 27, 304\u2013310 (2012).","journal-title":"Nephrol. Dial. Transplant."},{"key":"488_CR99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201591","volume":"13","author":"Y Kamei","year":"2018","unstructured":"Kamei, Y., Kamei, D., Tsuchiya, K., Mineshima, M. & Nitta, K. Association between 4-year all-cause mortality and carnitine profile in maintenance hemodialysis patients. PLoS One 13, e0201591 (2018).","journal-title":"PLoS One"},{"key":"488_CR100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/db12-0466","volume":"62","author":"MG Schooneman","year":"2013","unstructured":"Schooneman, M. G., Vaz, F. M., Houten, S. M. & Soeters, M. R. Acylcarnitines: reflecting or inflicting insulin resistance? Diabetes 62, 1\u20138 (2013).","journal-title":"Diabetes"},{"key":"488_CR101","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.cmet.2012.04.005","volume":"15","author":"DM Muoio","year":"2012","unstructured":"Muoio, D. M. et al. Muscle-specific deletion of carnitine acetyltransferase compromises glucose tolerance and metabolic flexibility. Cell Metab. 15, 764\u2013777 (2012).","journal-title":"Cell Metab."},{"key":"488_CR102","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2337\/db18-0090","volume":"68","author":"C Kruger","year":"2019","unstructured":"Kruger, C. et al. Proximal tubular cell-specific ablation of carnitine acetyltransferase causes tubular disease and secondary glomerulosclerosis. Diabetes 68, 819 (2019).","journal-title":"Diabetes"},{"key":"488_CR103","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3945\/ajcn.113.062802","volume":"99","author":"Y Chen","year":"2014","unstructured":"Chen, Y. et al. L-Carnitine supplementation for adults with end-stage kidney disease requiring maintenance hemodialysis: a systematic review and meta-analysis. Am. J. Clin. Nutr. 99, 408\u2013422 (2014).","journal-title":"Am. J. Clin. Nutr."},{"key":"488_CR104","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000355751","volume":"38","author":"H Huang","year":"2013","unstructured":"Huang, H. et al. Influence of L-carnitine supplementation on serum lipid profile in hemodialysis patients: a systematic review and meta-analysis. Kidney Blood Press. Res. 38, 31\u201341 (2013).","journal-title":"Kidney Blood Press. Res."},{"key":"488_CR105","first-page":"510483","volume":"2012","author":"AE Naini","year":"2012","unstructured":"Naini, A. E. et al. Effects of oral L-carnitine supplementation on lipid profile, anemia, and quality of life in chronic renal disease patients under hemodialysis: a randomized, double-blinded, placebo-controlled trial. J. Nutr. Metab. 2012, 510483 (2012).","journal-title":"J. Nutr. Metab."},{"key":"488_CR106","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/IJNRD.S101808","volume":"10","author":"I Mikolasevic","year":"2017","unstructured":"Mikolasevic, I., \u017dutelija, M., Mavrinac, V. & Orlic, L. Dyslipidemia in patients with chronic kidney disease: etiology and management. Int. J. Nephrol. Renov. Dis. 10, 35\u201345 (2017).","journal-title":"Int. J. Nephrol. Renov. Dis."},{"key":"488_CR107","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.clnu.2014.09.007","volume":"34","author":"C-I Ho","year":"2015","unstructured":"Ho, C.-I. et al. Relationship between TG\/HDL-C ratio and metabolic syndrome risk factors with chronic kidney disease in healthy adult population. Clin. Nutr. 34, 874\u2013880 (2015).","journal-title":"Clin. Nutr."},{"key":"488_CR108","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.metabol.2011.05.004","volume":"61","author":"G Zoppini","year":"2012","unstructured":"Zoppini, G. et al. Triglyceride\u2013high-density lipoprotein cholesterol is associated with microvascular complications in type 2 diabetes mellitus. Metabolism 61, 22\u201329 (2012).","journal-title":"Metabolism"},{"key":"488_CR109","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2215\/CJN.07320619","volume":"15","author":"JA Lamprea-Montealegre","year":"2020","unstructured":"Lamprea-Montealegre, J. A. et al. Apolipoprotein B, triglyceride-rich lipoproteins, and risk of cardiovascular events in persons with CKD. Clin. J. Am. Soc. Nephrol. 15, 47\u201360 (2020).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"488_CR110","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1681\/ASN.2009111132","volume":"21","author":"EP Rhee","year":"2010","unstructured":"Rhee, E. P. et al. Metabolite profiling identifies markers of uremia. J. Am. Soc. Nephrol. 21, 1041\u20132051 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"488_CR111","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2215\/CJN.08730816","volume":"12","author":"TI Chang","year":"2017","unstructured":"Chang, T. I. et al. Association of serum triglyceride to HDL cholesterol ratio with all-cause and cardiovascular mortality in incident hemodialysis patients. Clin. J. Am. Soc. Nephrol. 12, 591\u2013602 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"488_CR112","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12944-019-1147-8","volume":"18","author":"X Zhan","year":"2019","unstructured":"Zhan, X. et al. Triglyceride to high-density lipoprotein cholesterol ratio is associated with increased mortality in older patients on peritoneal dialysis. Lipids Health Dis. 18, 199 (2019).","journal-title":"Lipids Health Dis."},{"key":"488_CR113","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.bbamcr.2016.01.023","volume":"1863","author":"N Longo","year":"2016","unstructured":"Longo, N., Frigeni, M. & Pasquali, M. Carnitine transport and fatty acid oxidation. Biochim. Biophys. Acta 1863, 2422\u20132435 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"488_CR114","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00125-010-1951-1","volume":"54","author":"TME Davis","year":"2011","unstructured":"Davis, T. M. E. et al. Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia 54, 280\u2013290 (2011).","journal-title":"Diabetologia"},{"key":"488_CR115","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.jacc.2012.07.049","volume":"60","author":"M Jun","year":"2012","unstructured":"Jun, M. et al. Effects of fibrates in kidney disease: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 60, 2061\u20132071 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"488_CR116","volume":"17","author":"KM Sas","year":"2021","unstructured":"Sas, K. M. et al. Renin-angiotensin system inhibition reverses the altered triacylglycerol metabolic network in diabetic kidney disease. Metabolomics 17, 65 (2021).","journal-title":"Metabolomics"},{"key":"488_CR117","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2215\/CJN.10010818","volume":"14","author":"S Luo","year":"2019","unstructured":"Luo, S. et al. Serum metabolomic alterations associated with proteinuria in CKD. Clin. J. Am. Soc. Nephrol. 14, 342\u2013353 (2019).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"488_CR118","doi-asserted-by":"crossref","first-page":"419","DOI":"10.15761\/JTS.1000419","volume":"6","author":"F Afshinnia","year":"2020","unstructured":"Afshinnia, F. et al. Plasma lipidomic profiling identifies a novel complex lipid signature associated with ischemic stroke in chronic kidney disease. J. Transl. Sci. 6, 419 (2020).","journal-title":"J. Transl. Sci."},{"key":"488_CR119","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.bbamem.2017.04.006","volume":"1859","author":"JN van der Veen","year":"2017","unstructured":"van der Veen, J. N. et al. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochim. Biophys. Acta 1859, 1558\u20131572 (2017).","journal-title":"Biochim. Biophys. Acta"},{"key":"488_CR120","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bbalip.2012.08.016","volume":"1831","author":"JE Vance","year":"2013","unstructured":"Vance, J. E. & Tasseva, G. Formation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cells. Biochim. Biophys. Acta 1831, 543\u2013554 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"488_CR121","doi-asserted-by":"crossref","first-page":"40131","DOI":"10.1074\/jbc.M112.399428","volume":"287","author":"EYL Chan","year":"2012","unstructured":"Chan, E. Y. L. & McQuibban, G. A. Phosphatidylserine decarboxylase 1 (Psd1) promotes mitochondrial fusion by regulating the biophysical properties of the mitochondrial membrane and alternative topogenesis of mitochondrial genome maintenance protein 1 (Mgm1). J. Biol. Chem. 287, 40131\u201340139 (2012).","journal-title":"J. Biol. Chem."},{"key":"488_CR122","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.devcel.2017.11.023","volume":"44","author":"JR Friedman","year":"2018","unstructured":"Friedman, J. R. et al. Lipid homeostasis is maintained by dual targeting of the mitochondrial PE biosynthesis enzyme to the ER. Dev. Cell 44, 261\u2013270.e6 (2018).","journal-title":"Dev. Cell"},{"key":"488_CR123","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1074\/jbc.M112.434183","volume":"288","author":"G Tasseva","year":"2013","unstructured":"Tasseva, G. et al. Phosphatidylethanolamine deficiency in mammalian mitochondria impairs oxidative phosphorylation and alters mitochondrial morphology. J. Biol. Chem. 288, 4158\u20134173 (2013).","journal-title":"J. Biol. Chem."},{"key":"488_CR124","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1152\/japplphysiol.00664.2015","volume":"120","author":"SA Newsom","year":"2016","unstructured":"Newsom, S. A. et al. Skeletal muscle phosphatidylcholine and phosphatidylethanolamine are related to insulin sensitivity and respond to acute exercise in humans. J. Appl. Physiol. 120, 1355\u20131363 (2016).","journal-title":"J. Appl. Physiol."},{"key":"488_CR125","volume":"8","author":"S Lee","year":"2018","unstructured":"Lee, S. et al. Skeletal muscle phosphatidylcholine and phosphatidylethanolamine respond to exercise and influence insulin sensitivity in men. Sci. Rep. 8, 6531 (2018).","journal-title":"Sci. Rep."},{"key":"488_CR126","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.2337\/db13-0993","volume":"63","author":"JN van der Veen","year":"2014","unstructured":"van der Veen, J. N., Lingrell, S., da Silva, R. P., Jacobs, R. L. & Vance, D. E. The concentration of phosphatidylethanolamine in mitochondria can modulate ATP production and glucose metabolism in mice. Diabetes 63, 2620\u20132630 (2014).","journal-title":"Diabetes"},{"key":"488_CR127","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/99b0e7bf-5878-42de-bcce-719ceea15466","volume":"9","author":"M Watanabe","year":"2014","unstructured":"Watanabe, M. et al. Pemt deficiency ameliorates endoplasmic reticulum stress in diabetic nephropathy. PLoS One 9, e92647 (2014).","journal-title":"PLoS One"},{"key":"488_CR128","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1089\/ars.2017.7129","volume":"28","author":"OM Bhat","year":"2018","unstructured":"Bhat, O. M., Yuan, X., Li, G., Lee, R. & Li, P.-L. Sphingolipids and redox signaling in renal regulation and chronic kidney diseases. Antioxid. Redox Signal. 28, 1008\u20131026 (2018).","journal-title":"Antioxid. Redox Signal."},{"key":"488_CR129","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.semnephrol.2018.01.007","volume":"38","author":"JA Shayman","year":"2018","unstructured":"Shayman, J. A. Targeting glucosylceramide synthesis in the treatment of rare and common renal disease. Semin. Nephrol. 38, 183\u2013192 (2018).","journal-title":"Semin. Nephrol."},{"key":"488_CR130","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.cellsig.2010.04.006","volume":"22","author":"J Mesicek","year":"2010","unstructured":"Mesicek, J. et al. Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in HeLa cells. Cell. Signal. 22, 1300\u20131307 (2010).","journal-title":"Cell. Signal."},{"key":"488_CR131","doi-asserted-by":"crossref","first-page":"7485","DOI":"10.1073\/pnas.1804266115","volume":"115","author":"AK Rudd","year":"2018","unstructured":"Rudd, A. K. & Devaraj, N. K. Traceless synthesis of ceramides in living cells reveals saturation-dependent apoptotic effects. Proc. Natl Acad. Sci. USA 115, 7485\u20137490 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"488_CR132","doi-asserted-by":"crossref","first-page":"101152","DOI":"10.1016\/j.diabet.2020.03.003","volume":"47","author":"A Mantovani","year":"2021","unstructured":"Mantovani, A. et al. Association between increased plasma ceramides and chronic kidney disease in patients with and without ischemic heart disease. Diabetes Metab. 47, 101152 (2021).","journal-title":"Diabetes Metab."},{"key":"488_CR133","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.metabol.2014.07.001","volume":"63","author":"RL Klein","year":"2014","unstructured":"Klein, R. L. et al. Decreased plasma levels of select very long chain ceramide species are associated with the development of nephropathy in type 1 diabetes. Metabolism 63, 1287\u20131295 (2014).","journal-title":"Metabolism"},{"key":"488_CR134","first-page":"002","volume":"S14","author":"KM Sas","year":"2015","unstructured":"Sas, K. M. et al. Targeted lipidomic and transcriptomic analysis identifies dysregulated renal ceramide metabolism in a mouse model of diabetic kidney disease. J. Proteom. Bioinform. S14, 002 (2015).","journal-title":"J. Proteom. Bioinform."},{"key":"488_CR135","doi-asserted-by":"crossref","first-page":"581","DOI":"10.4093\/dmj.2019.0063","volume":"44","author":"C-Y Woo","year":"2020","unstructured":"Woo, C.-Y. et al. Inhibition of ceramide accumulation in podocytes by myriocin prevents diabetic nephropathy. Diabetes Metab. J. 44, 581\u2013591 (2020).","journal-title":"Diabetes Metab. J."},{"key":"488_CR136","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1194\/jlr.M076745","volume":"58","author":"TV Dupre","year":"2017","unstructured":"Dupre, T. V. et al. Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury. J. Lipid Res. 58, 1439\u20131452 (2017).","journal-title":"J. Lipid Res."},{"key":"488_CR137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2018.12.031","volume":"26","author":"SM Turpin-Nolan","year":"2019","unstructured":"Turpin-Nolan, S. M. et al. CerS1-derived C18:0 ceramide in skeletal muscle promotes obesity-induced insulin resistance. Cell Rep. 26, 1\u201310.e7 (2019).","journal-title":"Cell Rep."},{"key":"488_CR138","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cmet.2014.09.015","volume":"20","author":"S Raichur","year":"2014","unstructured":"Raichur, S. et al. CerS2 haploinsufficiency inhibits \u03b2-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance. Cell Metab. 20, 687\u2013695 (2014).","journal-title":"Cell Metab."},{"key":"488_CR139","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-10584-4","volume":"10","author":"A Mitrofanova","year":"2019","unstructured":"Mitrofanova, A. et al. SMPDL3b modulates insulin receptor signaling in diabetic kidney disease. Nat. Commun. 10, 2692 (2019).","journal-title":"Nat. Commun."},{"key":"488_CR140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1681\/ASN.2013111213","volume":"26","author":"T-H Yoo","year":"2015","unstructured":"Yoo, T.-H. et al. Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease. J. Am. Soc. Nephrol. 26, 133\u2013147 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"488_CR141","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1023\/A:1020575001944","volume":"47","author":"F Jimenez","year":"2002","unstructured":"Jimenez, F., Monte, M. J., El-Mir, M. Y., Pascual, M. J. & Marin, J. J. G. Chronic renal failure-induced changes in serum and urine bile acid profiles. Dig. Dis. Sci. 47, 2398\u20132406 (2002).","journal-title":"Dig. Dis. Sci."},{"key":"488_CR142","volume":"7","author":"R Li","year":"2019","unstructured":"Li, R. et al. Targeted metabolomics study of serum bile acid profile in patients with end-stage renal disease undergoing hemodialysis. PeerJ 7, e7145 (2019).","journal-title":"PeerJ"},{"key":"488_CR143","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/j.ajkd.2017.06.017","volume":"71","author":"A Jovanovich","year":"2018","unstructured":"Jovanovich, A. et al. Deoxycholic acid, a metabolite of circulating bile acids, and coronary artery vascular calcification in CKD. Am. J. Kidney Dis. 71, 27\u201334 (2018).","journal-title":"Am. J. Kidney Dis."},{"key":"488_CR144","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11255-014-0901-0","volume":"47","author":"L Chu","year":"2015","unstructured":"Chu, L., Zhang, K., Zhang, Y., Jin, X. & Jiang, H. Mechanism underlying an elevated serum bile acid level in chronic renal failure patients. Int. Urol. Nephrol. 47, 345\u2013351 (2015).","journal-title":"Int. Urol. Nephrol."},{"key":"488_CR145","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1136\/gutjnl-2019-319766","volume":"69","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents. Gut 69, 2131\u20132142 (2020).","journal-title":"Gut"},{"key":"488_CR146","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1681\/ASN.2014121271","volume":"27","author":"XX Wang","year":"2016","unstructured":"Wang, X. X. et al. G protein-coupled bile acid receptor TGR5 activation inhibits kidney disease in obesity and diabetes. J. Am. Soc. Nephrol. 27, 1362\u20131378 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"488_CR147","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1681\/ASN.2017020222","volume":"29","author":"XX Wang","year":"2018","unstructured":"Wang, X. X. et al. FXR\/TGR5 dual agonist prevents progression of nephropathy in diabetes and obesity. J. Am. Soc. Nephrol. 29, 118\u2013137 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"488_CR148","doi-asserted-by":"crossref","first-page":"F1587","DOI":"10.1152\/ajprenal.00404.2009","volume":"297","author":"XX Wang","year":"2009","unstructured":"Wang, X. X. et al. The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria. Am. J. Physiol. Ren. Physiol. 297, F1587\u2013F1596 (2009).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"488_CR149","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.2337\/db06-1642","volume":"56","author":"T Jiang","year":"2007","unstructured":"Jiang, T. et al. Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy. Diabetes 56, 2485\u20132493 (2007).","journal-title":"Diabetes"},{"key":"488_CR150","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1021\/acs.jmedchem.9b01621","volume":"63","author":"D Chianelli","year":"2020","unstructured":"Chianelli, D. et al. Nidufexor (LMB763), a novel FXR modulator for the treatment of nonalcoholic steatohepatitis. J. Med. Chem. 63, 3868\u20133880 (2020).","journal-title":"J. Med. Chem."},{"key":"488_CR151","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03804879 (2021)."},{"key":"488_CR152","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.coph.2017.09.008","volume":"37","author":"H Malhi","year":"2017","unstructured":"Malhi, H. & Camilleri, M. Modulating bile acid pathways and TGR5 receptors for treating liver and GI diseases. Curr. Opin. Pharmacol. 37, 80\u201386 (2017).","journal-title":"Curr. Opin. Pharmacol."},{"key":"488_CR153","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1194\/jlr.M077222","volume":"59","author":"KM Sas","year":"2018","unstructured":"Sas, K. M. et al. Shared and distinct lipid-lipid interactions in plasma and affected tissues in a diabetic mouse model. J. Lipid Res. 59, 173\u2013183 (2018).","journal-title":"J. Lipid Res."},{"key":"488_CR154","doi-asserted-by":"crossref","first-page":"460849","DOI":"10.1016\/j.chroma.2020.460849","volume":"1618","author":"JY Eum","year":"2020","unstructured":"Eum, J. Y. et al. Aging-related lipidomic changes in mouse serum, kidney, and heart by nanoflow ultrahigh-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 1618, 460849 (2020).","journal-title":"J. Chromatogr. A"},{"key":"488_CR155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2337\/db19-0043","volume":"69","author":"SM Tan","year":"2020","unstructured":"Tan, S. M. et al. Complement C5a induces renal injury in diabetic kidney disease by disrupting mitochondrial metabolic agility. Diabetes 69, 83\u201398 (2020).","journal-title":"Diabetes"},{"key":"488_CR156","volume":"16","author":"G Zhang","year":"2020","unstructured":"Zhang, G. et al. DESI-MSI and METASPACE indicates lipid abnormalities and altered mitochondrial membrane components in diabetic renal proximal tubules. Metabolomics 16, 11 (2020).","journal-title":"Metabolomics"},{"key":"488_CR157","doi-asserted-by":"crossref","first-page":"F1545","DOI":"10.1152\/ajprenal.00395.2007","volume":"295","author":"Y Mizuguchi","year":"2008","unstructured":"Mizuguchi, Y. et al. A novel cell-permeable antioxidant peptide decreases renal tubular apoptosis and damage in unilateral ureteral obstruction. Am. J. Physiol. Ren. Physiol. 295, F1545\u2013F1553 (2008).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"488_CR158","doi-asserted-by":"crossref","first-page":"F547","DOI":"10.1152\/ajprenal.00574.2014","volume":"310","author":"Y Hou","year":"2015","unstructured":"Hou, Y. et al. Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy. Am. J. Physiol. Ren. Physiol. 310, F547\u2013F559 (2015).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"488_CR159","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.kint.2018.06.031","volume":"94","author":"A Mitrofanova","year":"2018","unstructured":"Mitrofanova, A. et al. Hydroxypropyl-\u03b2-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis. Kidney Int. 94, 1151\u20131159 (2018).","journal-title":"Kidney Int."},{"key":"488_CR160","volume":"14","author":"J-H Ryu","year":"2019","unstructured":"Ryu, J.-H. et al. APOL1 renal risk variants promote cholesterol accumulation in tissues and cultured macrophages from APOL1 transgenic mice. PLoS One 14, e0211559 (2019).","journal-title":"PLoS One"},{"key":"488_CR161","doi-asserted-by":"crossref","unstructured":"Isaac, G. in Metabolic Profiling: Methods and Protocols (ed. Metz, T. O.) 259\u2013275 (Humana Press, 2011).","DOI":"10.1007\/978-1-61737-985-7_16"},{"key":"488_CR162","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.steroids.2011.11.008","volume":"77","author":"X Qiao","year":"2012","unstructured":"Qiao, X. et al. A tandem mass spectrometric study of bile acids: interpretation of fragmentation pathways and differentiation of steroid isomers. Steroids 77, 204\u2013211 (2012).","journal-title":"Steroids"},{"key":"488_CR163","first-page":"204","volume":"3","author":"JJJ van der Hooft","year":"2015","unstructured":"van der Hooft, J. J. J., Ridder, L., Barrett, M. P. & Burgess, K. E. V. Enhanced acylcarnitine annotation in high-resolution mass spectrometry data: fragmentation analysis for the classification and annotation of acylcarnitines. Front. Bioeng. Biotechnol. 3, 204 (2015).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"488_CR164","doi-asserted-by":"crossref","first-page":"22335","DOI":"10.1039\/C8RA01574K","volume":"8","author":"JL Ren","year":"2018","unstructured":"Ren, J. L., Zhang, A. H., Kong, L. & Wang, X. J. Advances in mass spectrometry-based metabolomics for investigation of metabolites. RSC Adv. 8, 22335\u201322350 (2018).","journal-title":"RSC Adv."},{"key":"488_CR165","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3390\/ijms20071623","volume":"20","author":"I Abbas","year":"2019","unstructured":"Abbas, I. et al. Kidney lipidomics by mass spectrometry imaging: a focus on the glomerulus. Int. J. Mol. Sci. 20, 1623 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"488_CR166","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1007\/s00216-019-01719-z","volume":"411","author":"S Wernisch","year":"2019","unstructured":"Wernisch, S. & Pennathur, S. Application of differential mobility-mass spectrometry for untargeted human plasma metabolomic analysis. Anal. Bioanal. Chem. 411, 6297\u20136308 (2019).","journal-title":"Anal. Bioanal. Chem."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-021-00488-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-021-00488-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-021-00488-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T04:07:22Z","timestamp":1699589242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-021-00488-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,6]]},"references-count":166,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["488"],"URL":"https:\/\/doi.org\/10.1038\/s41581-021-00488-2","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,6]]},"assertion":[{"value":"6 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}